BioDelivery Sciences International, Inc. v. Reckitt Benckiser Pharmaceuticals, Inc. et al

No. 5:14-cv-00529, North Carolina Eastern District Court

Last updated: Mar 22, 2022 20:04pm EDT

Stock Tags
$BDSI
Case Title
BioDelivery Sciences International, Inc. v. Reckitt Benckiser Pharmaceuticals, Inc. et al
Docket Index Number
5:14-cv-00529
Date Opened
Sep 20, 2014
Date Closed
Mar 10, 2021
Case Type
Civil Case
Cause of Action
28:2201 Declaratory Judgment
Nature of Suit
830 Patent
Judge
Richard E. Myers, II
Case Number
5:2014cv529
PACER Docket Link
Access Docket on PACER
(Separate PACER login required)

Docket Sheet

Dkt # 1
Sep 20, 2014
COMPLAINT against All Defendants ( Filing fee $ 400 receipt number 0417-3036646.), filed by BioDelivery Sciences International, Inc.. (Attachments: # 1 Civil Cover Sheet, # 2 Proposed Summons Reckitt Benckiser Pharmaceuticals, Inc., # 3 Proposed Summons RB Pharmaceuticals Limited, # 4 Proposed Summons MonoSol Rx, LLC, # 5 Exhibit A - U.S. Patent No. 8,475,832, # 6 Exhibit B - U.S. Patent No. 7,897,080, # 7 Exhibit C - U.S. Patent No. 8,652,378) (Borchers, Lynne) (Entered: 09/20/2014)
Dkt # 2
Sep 20, 2014
FINANCIAL DISCLOSURE STATEMENT by BioDelivery Sciences International, Inc. (Borchers, Lynne) (Entered: 09/20/2014)
Dkt # 3
Sep 22, 2014
PATENT REPORT: Copy of report and complaint forwarded to the Director of the U.S. Patent and Trademark Office, P.O. Box 1450 Alexandria, VA 22313-1450 via first class mail on 9/22/2014. (Felder, J) (Entered: 09/22/2014)

Newer docket entries may be available. Subscribe to access new filings

Unlock instant access to this case

Download every filing.
Automated case monitoring.
Email alerts for new docket activity.

Purchase Now